1-Aminomethylindane
![]() | |
Names | |
---|---|
IUPAC name
2,3-dihydro-1H-inden-1-ylmethanamine
| |
Other names
1-AMI
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ChemSpider | |
EC Number |
|
PubChem CID
|
|
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C10H13N | |
Molar mass | 147.221 g·mol−1 |
Hazards | |
GHS labelling:[1] | |
![]() ![]() | |
Danger | |
H302, H315, H318, H335 | |
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P330, P332+P317, P362+P364, P403+P233, P405, P501 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
1-Aminomethylindane (1-AMI) is a chemical compound and derivative of indane. It can also be thought of as a cyclized phenethylamine or β-phenethylamine derivative in which the side chain is cyclized with the benzene ring. 1-AMI is the parent compound of a group of psychedelic- and entactogen-related drugs that includes 1-aminomethyl-5-methoxyindane (1-AMMI; related to para-methoxyamphetamine (PMA)), 2CB-Ind (related to 2C-B), jimscaline (related to mescaline), and bromojimscaline (related to 2-bromomescaline).[1][2][3]
See also
[edit]References
[edit]- ^ Trachsel, D.; Lehmann, D.; Enzensperger, C. (2013). Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag. ISBN 978-3-03788-700-4. OCLC 858805226. Retrieved 31 January 2025.
- ^ Blaazer AR, Smid P, Kruse CG (September 2008). "Structure-activity relationships of phenylalkylamines as agonist ligands for 5-HT(2A) receptors". ChemMedChem. 3 (9): 1299–1309. doi:10.1002/cmdc.200800133. PMID 18666267.
- ^ McLean TH, Chambers JJ, Parrish JC, Braden MR, Marona-Lewicka D, Kurrasch-Orbaugh D, Nichols DE (July 2006). "C-(4,5,6-trimethoxyindan-1-yl)methanamine: a mescaline analogue designed using a homology model of the 5-HT2A receptor". J Med Chem. 49 (14): 4269–4274. doi:10.1021/jm060272y. PMID 16821786.